A new study conducted by Indiana University School of Medicine researchers has found that primary care screenings for Alzheimer's disease and related dementias (ADRD) in older adults did not cause psychological distress for ...
Apr 27, 2026
0
6
For patients with early Alzheimer's disease and mild cognitive impairment, cognition is consistently improved with multimodal lifestyle interventions (MMLIs), while monoclonal antibodies (MABs) clear amyloid plaques but only ...
Apr 22, 2026
0
3
A new study has answered a question that has puzzled cancer researchers for decades: Does a genetic defect found in nearly all human colorectal cancers simply accompany the disease, or does it trigger its development? A team ...
Apr 1, 2026
0
5
Over 95% of the world's adult population is infected with Epstein-Barr virus (EBV), but most people never realize it. The infection often causes few symptoms and then stays in the body for life.
Feb 20, 2026
0
16
A protein made by stressed cancer cells helps lung and pancreatic tumors evade the immune system, a new study shows. Led by researchers from NYU Langone Health, the work found that new drugs designed to block the action of ...
Feb 18, 2026
0
29
Researchers have developed a nasal spray for flu prevention that has shown promising results in preliminary human trials. Seasonal influenza (the flu) is an acute respiratory infection that affects up to one billion people ...
Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis. Antibodies recognize and bind to very specific structures. This allows them to direct active substances ...
Dec 17, 2025
0
14
New research, published in Nature, has provided the first ever population-based data on the frequency of Alzheimer's disease neuropathological changes (ADNC)—a key causal factor behind the development of dementia—and found ...
Dec 17, 2025
0
36
A new artificial intelligence model could help design antibodies that better protect the body against viruses and disease. The AI model, known as ImmunoMatch, can predict and identify correct protein pairings within antibodies, ...
Dec 16, 2025
0
13
Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have created the most comprehensive map to date showing how antibodies attach to the SARS-CoV-2 virus, which causes COVID-19, and how viral mutations ...
Nov 21, 2025
0
41
